Position in ZTS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,013,872
-$788,475 QoQ
Shares Held
14,109
-7.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#640
of 1,413 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $15,358,516 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
22,585 | $12,237,230 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
14,109 | $1,013,872 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,568 | $432,810 | |
| 4 | VTRS |
Viatris Inc
|
22,397 | $355,664 | |
| 5 | LQDA |
Liquidia Corp
|
4,075 | $324,899 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,779 | $308,302 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,834 | $265,415 | |
| 8 | HLN |
Haleon plc
|
20,563 | $191,852 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,013,872 | 14,109 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,802,347 | 15,247 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,874,718 | 14,900 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,594,010 | 10,894 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,605,300 | 16,706 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,753,357 | 10,649 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,836,872 | 11,274 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,313,840 | 16,961 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,730,420 | 15,750 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,084,667 | 12,320 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,470,085 | 12,515 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,735,276 | 9,974 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,723,305 | 10,007 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,179,893 | 7,089 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $993,609 | 6,780 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $959,139 | 6,468 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,607,171 | 9,350 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,555,301 | 8,247 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,018,616 | 8,272 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,513,127 | 7,794 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,505,229 | 8,077 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,288,658 | 8,183 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $76,331 | 557 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||